Myself, I think it's too soon for a SHM when you consider Dr. Gulas just ,became CEO six weeks ago. Judging from the last quarter report I for one am very grateful that Dr. Gulas excepted the position and may very well be considered the savior of NTEK when you look at the financials. After increasing the o/s from r/s of 80 million to 140 million, ntek's last quarter had huge losses of $1.6 million after expenses and if you subtract the NTGL investment credit it was even greater. Dr. Gulas accepted no salary and has helped with a cash infusion of his money (to save ntek from possible default?) . Now that DF is back and from the limited info that has been shared with SH, the foundations needed for accelerated revenue growth are in place and they just need to execute. I am predicting that the fourth quarter of the fiscal year will be much improved and a SHM that follows will be better time to discuss where they were and where they are going.